BOSTON SCIENTIFIC CORP (BSX)

US1011371077 - Common Stock

67.33  -0.09 (-0.13%)

After market: 67.33 0 (0%)

News Image
12 days ago - Boston Scientific Corporation

Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the NAVIGATE-PF study of the FARAVIEW™ Software Module* when it is used to visualize...

News Image
19 days ago - Boston Scientific Corporation

Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first...

News Image
25 days ago - Scivita Medical

Scivita Medical Expands Collaboration with Boston Scientific

/CNW/ -- Recently, Scivita Medical Technology Co., Ltd. ("Scivita Medical") and Boston Scientific Corporation (NYSE: BSX), a leading global medical technology...

News Image
25 days ago - Scivita Medical

Scivita Medical Expands Collaboration with Boston Scientific

/PRNewswire/ -- Recently, Scivita Medical Technology Co., Ltd. ("Scivita Medical") and Boston Scientific Corporation (NYSE: BSX), a leading global medical...

News Image
a month ago - Investor's Business Daily

Why Abbott's Formula-Related Sell-Off Could Be A Buying Opportunity, Says Analyst

Fellow infant formula maker Reckitt Benckiser was ordered to pay $60 million to a mother whose baby died after eating Enfamil.

News Image
a month ago - Market News Video

BSX November 15th Options Begin Trading

News Image
a month ago - Investor's Business Daily

Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher

On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78.

News Image
a month ago - Bloomberg

Boston Scientific Likely Faces FTC Scrutiny on $3.7 Billion Axonics Deal

Boston Scientific Corp.’s proposed $3.7 billion acquisition of medical device maker Axonics Inc. will likely be scrutinized by the US Federal Trade Commission because the companies are the dominant providers of some treatments for urinary incontinence, according to antitrust experts.

News Image
2 months ago - Seeking Alpha

Boston Sci gets FDA approval for Agent in-stent restenosis balloon (NYSE:BSX)

Boston Scientific (BSX) said it has received FDA approval for its Agent Drug-Coated Balloon for the treatment of coronary in-stent restenosis. Read more here.

News Image
2 months ago - InvestorPlace

The Hot List: 3 AI Stocks Worth Buying on Weakness

Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness. 

News Image
2 months ago - Boston Scientific Corporation

Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the AGENT™...

News Image
2 months ago - Boston Scientific Corporation

Boston Scientific Announces Completion of €2.0 Billion Offering of Senior Notes

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) (the "Company") today announced that American Medical Systems Europe B.V., its wholly owned finance...

News Image
2 months ago - Seeking Alpha

Boston Scientific announces pricing of €2.0 billion of senior notes (NYSE:BSX)

Boston Scientific prices €2.0 billion senior notes public offering through its subsidiary, American Medical Systems Europe, with expected closing on Feb 27.

News Image
2 months ago - Boston Scientific Corporation

Boston Scientific Announces Pricing of €2.0 Billion of Senior Notes

/PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V., its wholly owned finance...

News Image
2 months ago - Seeking Alpha

Medtronic Q3 in focus amid MedTech gains (NYSE:MDT)

Medtronic is set to report its Q3 FY24 results, with high expectations following strong performances from its peers in the MedTech sector. Read more here.

News Image
2 months ago - Boston Scientific Corporation

Boston Scientific to Participate in TD Cowen's 44th Annual Health Care Conference

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 44th Annual Health Care Conference on Wednesday, March 6, 2024. Mike...

News Image
3 months ago - Investor's Business Daily

Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review

The Dow led the major indexes higher. Big techs diverged on results.

News Image
3 months ago - Investor's Business Daily

Stryker Stock Sees Relative Strength Rating Jump To 84

The Relative Strength (RS) Rating for Stryker stock jumped into a new percentile Thursday, with a rise from 76 to 84.